| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 治疗和/或预防剖腹产分娩的婴儿感染的方法 | CN200680047332.9 | 2006-10-06 | CN101330837A | 2008-12-24 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含糖醛酸低聚糖的且用于制造对剖腹产分娩的婴儿进行肠道给予的一种组合物的应用。 | ||||||
| 2 | 促进非自然分娩后的肠屏障完整成熟的方法 | CN201310722592.3 | 2006-10-06 | CN103816173B | 2017-12-12 | 琼希姆·施密特; 巩特尔·勃姆; 克里斯托弗·比尔曼 |
| 本申请涉及促进非自然分娩后的肠屏障完整成熟的方法。本发明涉及喂养及促进剖腹产婴儿健康的方法，包括给予剖腹产婴儿长链多不饱和脂肪酸和/或核苷酸。 | ||||||
| 3 | 刺激肠内菌群的方法 | CN201310148476.5 | 2006-10-20 | CN103230005B | 2016-03-16 | G·伯姆; B·斯塔尔; J·诺尔 |
| 本发明涉及喂养的方法及对经剖腹生产术分娩的婴儿施用的组合物及尤其是a）至少两种不同的微生物；或b）至少一种微生物和至少一种不消化的寡糖；或c）至少两种不同的双歧杆菌种、亚种或菌株在制备对经剖腹生产术分娩的婴儿经肠施用的组合物中的用途。因此可以刺激所述婴儿肠内菌群的健康发展。 | ||||||
| 4 | 预防剖腹产分娩的婴儿疾病的方法 | CN201210414761.2 | 2006-10-06 | CN102919663B | 2015-08-19 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物在制备用于肠道给予剖腹产分娩婴儿的组合物中的应用。 | ||||||
| 5 | 预防剖腹产分娩的婴儿疾病的方法 | CN200680047651.X | 2006-10-06 | CN101330838B | 2013-01-23 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物在制备用于肠道给予剖腹产分娩婴儿的组合物中的应用。 | ||||||
| 6 | 促进非自然分娩后的肠屏障完整成熟的方法 | CN201310722592.3 | 2006-10-06 | CN103816173A | 2014-05-28 | 琼希姆·施密特; 巩特尔·勃姆; 克里斯托弗·比尔曼 |
| 本申请涉及促进非自然分娩后的肠屏障完整成熟的方法。本发明涉及喂养及促进剖腹产婴儿健康的方法，包括给予剖腹产婴儿长链多不饱和脂肪酸和/或核苷酸。 | ||||||
| 7 | 刺激肠内菌群的方法 | CN201310148476.5 | 2006-10-20 | CN103230005A | 2013-08-07 | G·伯姆; B·斯塔尔; J·诺尔 |
| 本发明涉及喂养的方法及对经剖腹生产术分娩的婴儿施用的组合物及尤其是a）至少两种不同的微生物；或b）至少一种微生物和至少一种不消化的寡糖；或c）至少两种不同的双歧杆菌种、亚种或菌株在制备对经剖腹生产术分娩的婴儿经肠施用的组合物中的用途。因此可以刺激所述婴儿肠内菌群的健康发展。 | ||||||
| 8 | 预防剖腹产分娩的婴儿疾病的方法 | CN201210414761.2 | 2006-10-06 | CN102919663A | 2013-02-13 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物在制备用于肠道给予剖腹产分娩婴儿的组合物中的应用。 | ||||||
| 9 | 预防剖腹产分娩的婴儿疾病的方法 | CN200680047651.X | 2006-10-06 | CN101330838A | 2008-12-24 | 琼希姆·施密特; 伯恩德·斯塔尔; 詹·诺尔 |
| 本发明提供了一种包含非消化低聚糖的组合物的应用，这种组合物适用于肠道给予剖腹产婴儿。 | ||||||
| 10 | 刺激肠内菌群的方法 | CN200680035474.3 | 2006-10-20 | CN101272701A | 2008-09-24 | G·伯姆; B·斯塔尔; J·诺尔 |
| 本发明涉及喂养的方法及对经剖腹生产术分娩的婴儿施用的组合物及尤其是a)至少两种不同的微生物；或b)至少一种微生物和至少一种不消化的寡糖；或c)至少两种不同的双歧杆菌种、亚种或菌株在制备对经剖腹生产术分娩的婴儿经肠施用的组合物中的用途。因此可以刺激所述婴儿肠内菌群的健康发展。 | ||||||
| 11 | Prevention of a disease in infants which are birth by caesarean section | JP2008536530 | 2006-10-06 | JP2009512686A | 2009-03-26 | クノール、ヤン; シュミット、ヨアヒム; スタール、ベルント |
| 本発明は、帝王切開により出産された乳幼児に経腸的に投与するための組成物の製造のための、非消化性オリゴ糖を含む組成物の使用を提供する。
【選択図】 なし |
||||||
| 12 | Method for stimulating the intestinal flora | US14973166 | 2015-12-17 | US09596876B2 | 2017-03-21 | Günther Boehm; Bernd Stahl; Jan Knol |
| The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | ||||||
| 13 | Preventing diseases in infants delivered via caesarean section | US14813845 | 2015-07-30 | US09585416B2 | 2017-03-07 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 14 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | US14813845 | 2015-07-30 | US20150335053A1 | 2015-11-26 | Joachim SCHMITT; Bernd STAHL; Jan KNOL |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 15 | Preventing diseases in infants delivered via caesarean section | US14135171 | 2013-12-19 | US09107438B2 | 2015-08-18 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 16 | Preventing diseases in infants delivered via caesarean section | US12091011 | 2006-10-06 | US08715769B2 | 2014-05-06 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 17 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | US14135171 | 2013-12-19 | US20140105865A1 | 2014-04-17 | Joachim SCHMITT; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 18 | Methods and Compositions for Improved Digestion of Milk Oligosaccharides | US14305868 | 2014-06-16 | US20150010670A1 | 2015-01-08 | David Mills; Daniel Garrido; Santiago Ruiz-Moyano; Carlito Lebrilla; J. Bruce German |
| Pre-biotic compositions containing oligosaccharides and probiotic compositions useful for treatment of a subject are provided herein. Also provided are methods for administering probiotic or pre-biotic compositions. | ||||||
| 19 | Method for making shelf-stable poi food products from dryland and wetland taro | US12502114 | 2009-07-13 | US08613964B1 | 2013-12-24 | Pamela Day; Piikalama Boiser |
| A method and composition for making food products for benefiting health, including: inoculating dryland taro poi with fermented wetland taro poi; fermenting the inoculated dryland taro poi; dehydrating the fermented dryland taro poi; rehydrating the dehydrated dryland taro poi; pasteurizing the rehydrated dryland taro poi; reinoculating the pasteurized dryland taro poi with a poi starter culture; and adding nutrients to the reinoculated dryland taro poi. The poi starter culture includes a probiotic organism having a concentration of at least 2000 cfu/g. The nutrients added to the dryland taro poi include one or more selected from the group consisting of: xylose and inulin. The dryland taro poi and the wetland taro poi are in an amount in a ratio of 40:1 by weight, dryland to wetland. | ||||||
| 20 | PROBIOTIC BIFIDOBACTERIAL COMPOSITION IN ACCORDANCE WITH SECRETOR BLOOD GROUP STATUS | US13519493 | 2010-12-28 | US20120301435A1 | 2012-11-29 | Pirjo Wacklin; Jaana Matto; Harri Makivuokko |
| The present invention relates to a microbial or probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals of non-secretor blood group phenotype. The present invention further relates to a method of tailoring a microbial or probiotic composition based on the bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals non-secretor blood group phenotype. | ||||||
QQ群二维码
意见反馈
意见反馈